{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-003808","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2026-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.404711+00:00","generated_at":"2026-05-16T03:12:09.479618+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Integrated BioPharma Q2 revenue down 10.3%, swings to net loss of $0.8M","bullets":["Revenue $11.3M vs $12.6M Q2 prior year; operating loss $0.9M vs income $0.2M.","Net loss $0.8M vs net income $0.1M; diluted EPS $(0.03) vs $0.00.","Six-month revenue $24.0M vs $26.2M; operating loss $0.7M vs income $0.7M.","Two largest contract manufacturing customers accounted for ~89% of total revenue.","Selling and administrative expenses decreased slightly to $0.9M from $1.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-003808","json":"https://secwatch.observer/filing/0001437749-26-003808.json","markdown":"https://secwatch.observer/filing/0001437749-26-003808.md","text":"https://secwatch.observer/filing/0001437749-26-003808.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774926003808/0001437749-26-003808-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774926003808/inbp20260205_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:12:09.479618+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}